Enovid Nasal Spray
Enovid Nasal spray works by changing the PH in the nostrils this way way it keeps virus away from entering our bodies
​
The name Enovid rings to many since Enovid was the first ever Oral contraceptive pill in June 23, 1960, the FDA approved the sale of Enovid for use as an oral contraceptive. It was manufactured by G.D. Searle and Company.
​
these days Enovid is a nasal spray that can keep 99 of virus away from the body you can buy it by clicking here.
​
A nasal spray that will be marketed as capable of killing 99.9 percent of virus particles has started rolling off production lines in an Israeli factory.
The spray could have prevented much of the world’s COVID-19 infection, its inventor, Dr. Gilly Regev,
“We are hoping that our nasal spray will now save many lives of people in countries that are waiting for the vaccine,” said Regev, an Israeli-raised biochemist who co-founded the company SaNOtize and developed the spray in Canada. “This will be affordable and can be used for prevention, to protect from any respiratory viral infection.”
​
She said that it has been shown to be effective in the lab against a wide range of viruses, and said that new variants of the coronavirus won’t interfere with its effectiveness, emphasizing: “It contains a broad spectrum antiviral which kills all viruses and all variants.”
3D medical animation still shot showing the structure of a coronavirus (https://www.scientificanimations.com/coronavirus-symptoms-and-prevention-explained-through-medical-animation/)
Regev called Enovid a “hand sanitizer equivalent for the nose,” and said that it creates a physical barrier in the nasal passages to stop viruses along with a “chemical barrier” of nitric oxide, which is known for its antimicrobial qualities. “The nitric oxide means this is a special spray that doesn’t just block viruses but actually kills them,” she said.
​
​
​
Israel will become the first country where the spray is sold. The Health Ministry has given interim approval for its sale as a medical device suitable for people age 12 and up — meaning it could be used by many who aren’t yet approved for coronavirus vaccines — with packaging stating: “Scientifically tested to kill 99.9% of viruses within 2 minutes.”
A bottle of Enovid, a new antiviral nose spray that is being produced in Israel (courtesy of SaNOtize)
It has also been approved for sale in New Zealand, and approval is being sought in other countries, including the UK.
Regev said that the factory, in Ness Ziona near Tel Aviv, is working to produce a stock of 200,000 to 500,000 bottles by May. “After this we’re hoping to get to capacity of a million bottles a month,” the Hebrew University graduate said, adding: “I hope this product will bring pride and jobs to Israel.”
​
The claim on the packaging is based on testing in labs, during which a range of live viruses, including influenza and SARS-CoV-2, were subjected to the spray. She acknowledged that the experiments took place outside the human body, in test tubes, and do not provide definitive proof of how effective the spray will prove in nasal passages — though she said they are very encouraging.
Separate research, which isn’t referenced on the packaging, has suggested that the spray can lessen the impact of COVID-19 among those who are infected.
Last week, SaNOtize and Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, announced results of clinical trials indicating that the spray could prevent the transmission of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those already infected. The study has been submitted to a leading medical journal for review and publication.
​
The spray was fully developed by the time the pandemic struck, as it was invented mainly to fight influenza. Its innovation is the dosing procedure for nitric oxide. “It normally comes in gas cylinders and normally gets delivered to hospitals, but we wanted a practical way to deliver it as a liquid antimicrobial and have spent the last 12 years developing this,” said Regev.
Ingredients of the spray mix together when it is administered to form nitric oxide, she said, noting: “All components are used widely in the food industry and have a very strong safety profile.” Each bottle contains a month’s supply for one person to spray twice a day for protection against viruses.
She said: “Theoretically we could have distributed it a year ago, but we needed to negotiate regulatory approval. That’s the biggest frustration, that we’ve been trying 24/7 for a year to bring it to the market, and it could have saved a lot of lives. I believe it would’ve prevented infections and therefore reduced deaths.”
​
​
Enovid is a nitric oxide nasal spray which is designed to kill the respiratory viruses that cause COVID-19 in the nasal cavity. Enovid produces a reduction in viral load of SAR-CoV-2 within 24 hours of treatment in the upper airways, preventing it from incubating and spreading to the lungs.
​
-
ENOVID NASAL SPRAY is a nasal spray that changes the ph in the nostrils and creates a physical barrier that prevents foreign bodies from entering the body
-
Ingredients: Sodium chloride, Citric acid, HPMC, Sodium nitrite, Benzalkonium Chloride
-
Enovid can be used daily as a proactive measure; Apply 2-3 times daily (2 sprays per nostril during each use)
-
Enovid can be used daily as a proactive measure; Apply 2-3 times daily (2 sprays per nostril during each use) before and after suspected exposure to foreign bodies in high-risk environments
​
-
What is nitric oxide?
Nitric oxide (NO) is a well-understood, well-studied nano-molecule that naturally occurs in the body. It has several physiologic functions, including dilating blood vessels and helping regulate the body's immune response to infection. Its first therapeutic approval, in 1999, leveraged its selective vasodilatory effects for the hospital treatment of blue baby syndrome (persistent pulmonary hypertension of the newborn). Moreover, for decades, NO has also been studied for its potentially robust antimicrobial properties across a wide range of pathogens. Our studies show that when NO is delivered to a site of infection in the right dose (e.g. concentration and duration), it kills the pathogen, but is safe for the human cells.
-
How does nitric oxide kill pathogens?
Nitric oxide (NO) has multiple mechanisms of action (MOA) as an antimicrobial. As an antiviral, NO can prevent viruses from entering cells and replicating. NO rapidly inactivates the virus via conformational changes to the spike proteins and proteases, which lead to fast reduction in viral load. The molecule also has several MOA in single-celled organisms (bacteria and fungi), including DNA damage and inhibition of DNA repair, as well as lipid damage via lipid peroxidation, among others. These mechanisms make NO an effective antimicrobial, able to stand up to evolving variants and unlikely to lead to antimicrobial resistance. Importantly, NO can damage microbes at a dose that is safe for human cells.
​
3.What are the primary COVID-19 clinical study results?
Nitric oxide released by nasal spray reduced SARS-CoV-2 log viral RNA load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 48 to72 hours in two randomized, double blinded controlled studies. It was also shown to cut the time of positive (PCR) to negative by 50% in high-risk individuals (unvaccinated or over age 45 or with comorbidities).
​
​4.What are the primary COVID-19 clinical study results?
Nitric oxide released by nasal spray reduced SARS-CoV-2 log viral RNA load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 48 to72 hours in two randomized, double blinded controlled studies. It was also shown to cut the time of positive (PCR) to negative by 50% in high-risk individuals (unvaccinated or over age 45 or with comorbidities).
Respiratory Therapy, Spring 2023: Epidemiological Analysis of Nitric Oxide Nasal Spray (VirX™) Use in Students Exposed to COVID-19 Infected Individuals
https://www.journalofinfection.com/article/S0163-4453(21)00251-6/fulltext
​
​5.How do I use enovid
Please refer to the User Guide.
Please note that each box of the product is arriving with a User Guide insert that has instructions in a variety of languages. These may include Hebrew, English, Russian, Arabic, Thai, German, etc.
A treatment consists of 2 alternating sprays per nostril for a total of 4 sprays per dose. As per user instructions, recommended dosing is 3 to 4 times daily as a preventative measure. Similar to using hand sanitizers, it should be used before and/or after potential exposure, up to 6 treatments per day. If you are experiencing any cold or flu like symptoms, we recommend using the spray more often; it can be safely used up to 6 treatments a day.
​
​
​